sirolimus has been researched along with Skin-Diseases--Vascular* in 6 studies
6 other study(ies) available for sirolimus and Skin-Diseases--Vascular
| Article | Year |
|---|---|
Comment on "Sirolimus for the treatment of verrucous venous malformation: A retrospective cohort study": Are we missing the lymphatic malformation component?
Topics: Hemangioma; Humans; Retrospective Studies; Sirolimus; Skin Diseases, Vascular; Skin Neoplasms | 2023 |
Reply to "Comment on 'Sirolimus for the treatment of verrucous venous malformation: A retrospective cohort study': Are we missing the lymphatic malformation component?"
Topics: Hemangioma; Humans; Retrospective Studies; Sirolimus; Skin Diseases, Vascular; Skin Neoplasms | 2023 |
Topical rapamycin in superficial lymphatic malformation: Microcystic lymphatic malformation or verrucous venous malformation?
Topics: Humans; Immunosuppressive Agents; Lymphatic Abnormalities; Sirolimus; Skin Diseases, Vascular | 2023 |
Histologic features of graft-versus-host disease-associated angiomatosis: Insights into pathophysiology and treatment.
Topics: Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Angiomatosis; Graft vs Host Disease; Humans; Mechanistic Target of Rapamycin Complex 1; Sirolimus; Skin; Skin Diseases, Vascular; Vascular Endothelial Growth Factor A | 2020 |
Sirolimus for treatment of verrucous venous malformation: A retrospective cohort study.
Topics: Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Prognosis; Retrospective Studies; Risk Assessment; Sirolimus; Skin Diseases, Vascular; Treatment Outcome; Vascular Malformations; Veins; Warts | 2019 |
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum: A brief report.
A patient with extensive multisystem overgrowth caused by a somatic gain of function PIK3CA-mutation is described. This case is an example of the clinical diversity of the PIK3CA-Related Overgrowth Spectrum (PROS) as the patient had overlapping features of Congenital Lipomatous Overgrowth Vascular malformations Epidermal nevi and Skeletal abnormalities (CLOVES) syndrome and Megalencephaly-Capillary malformation Polymicrogyria (MCAP) syndrome and underlines the utility of this umbrella term. Topics: Abnormalities, Multiple; Base Sequence; Bronchodilator Agents; Class I Phosphatidylinositol 3-Kinases; Diagnosis, Differential; Enteral Nutrition; Humans; Immunosuppressive Agents; Infant, Newborn; Lipoma; Male; Megalencephaly; Musculoskeletal Abnormalities; Mutation; Nevus; Phenotype; Respiration, Artificial; Sirolimus; Skin Diseases, Vascular; Telangiectasis; Vascular Malformations | 2018 |